NCT02037711View on ClinicalTrials.gov

Intraperitoneal Application of Levobupivacaine During Laparoscopic Surgery in Kids.

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Pain
Interventions
DRUG

Levobupivacaine 0.5%

Group I (Chirocaine group) (n=20): Levobupivacaine 0.5% will be instilled during insufflations of CO2 at the beginning of surgery at a dose of 2mg/kg.

DRUG

Normal saline

Group II (control group) (n=20): laparoscopy done with instillation of normal saline instead of levobupivacain

Trial Locations (1)

11562

Faculty of medicine, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02037711 - Intraperitoneal Application of Levobupivacaine During Laparoscopic Surgery in Kids. | Biotech Hunter | Biotech Hunter